Knoll Capital Management, LLC
13F Reported Value
ⓘ$179.3M
Holdings
37
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Knoll Capital Management, LLC disclosed 37 positions worth $179.3M in its Form 13F-HR for Q2 2026, led by $MGTX (MeiraGTx Holdings plc) at 9.4% of the equity portfolio, followed by $PHYS and $ALDX. During the quarter the fund opened 1 new position and exited 1 — including a new stake in $ABVX and a full exit from $CRDL. The portfolio is most concentrated in Healthcare (40.3% of disclosed assets). All figures are sourced directly from Knoll Capital Management, LLC’s Form 13F-HR filing with the SEC under CIK 1325083.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- —
Quality
$16.9M1,250,000 sh - —
Quality
$11.7M387,055 sh - —
Quality
$11.7M5,475,516 sh - 8.4
Quality
$11.3M1,150,400 sh - 79.7
Quality
$10.5M52,750 sh - —
Quality
$10.4M5,881,879 sh - 37.9
Quality
$9.1M1,598,591 sh - —
Quality
$8.2M52,750 sh - —
Quality
$8.2M317,003 sh - —
Quality
$7.6M320,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 MeiraGTx Holdings plc$MGTX | — | $16.9M | 1,250,000 |
 Sprott Physical Gold Trust$PHYS | — | $11.7M | 387,055 |
 Aldeyra Therapeutics, Inc.$ALDX | — | $11.7M | 5,475,516 |
 OCULAR THERAPEUTIX, INC$OCUL | 8.4 | $11.3M | 1,150,400 |
 ROYAL GOLD INC$RGLD | 79.7 | $10.5M | 52,750 |
 Entera Bio Ltd.$ENTX | — | $10.4M | 5,881,879 |
 Nuvation Bio Inc.$NUVB | 37.9 | $9.1M | 1,598,591 |
 AGNICO EAGLE MINES LTD$AEM | — | $8.2M | 52,750 |
 SEABRIDGE GOLD INC$SA | — | $8.2M | 317,003 |
 KINROSS GOLD CORP$KGC | — | $7.6M | 320,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Knoll Capital Management, LLC's 37 positions.
Showing top 10 of 37 holdings.
Sector Allocation
Healthcare
$72.3M
Materials
$58.9M
Financials
$37.6M
Technology
$6.8M
Other
$1.9M
Consumer Staples
$1.8M
Full Holdings — Knoll Capital Management, LLC (Q2 2026)
All 37 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $MGTX | MeiraGTx Holdings plc | $16.9M | 9.4% | +0% | — |
| 2 | $PHYS | Sprott Physical Gold Trust | $11.7M | 6.5% | +0% | — |
| 3 | $ALDX | Aldeyra Therapeutics, Inc. | $11.7M | 6.5% | +0% | — |
| 4 | $OCUL | OCULAR THERAPEUTIX, INC | $11.3M | 6.3% | +92% | 8.4 |
| 5 | $RGLD | ROYAL GOLD INC | $10.5M | 5.9% | +0% | 79.7 |
| 6 | $ENTX | Entera Bio Ltd. | $10.4M | 5.8% | +0% | — |
| 7 | $NUVB | Nuvation Bio Inc. | $9.1M | 5.1% | +7% | 37.9 |
| 8 | $AEM | AGNICO EAGLE MINES LTD | $8.2M | 4.6% | +0% | — |
| 9 | $SA | SEABRIDGE GOLD INC | $8.2M | 4.5% | +0% | — |
| 10 | $KGC | KINROSS GOLD CORP | $7.6M | 4.2% | +0% | — |
| 11 |  $OR | OR Royalties Inc. | $7.1M | 4.0% | +0% | — |
| 12 |  $SSRM | SSR MINING INC. | $6.9M | 3.9% | +0% | 58.3 |
| 13 |  $FNV | FRANCO NEVADA Corp | $6.7M | 3.7% | +0% | — |
| 14 |  $BAH | Booz Allen Hamilton Holding Corp | $5.7M | 3.2% | +0% | 58 |
| 15 |  $CGAU | Centerra Gold Inc. | $5.7M | 3.2% | +0% | — |
| 16 |  $ELTX | Elicio Therapeutics, Inc. | $4.7M | 2.6% | +92% | — |
| 17 |  $ABVX | Abivax S.A. | $4.7M | 2.6% | NEW | — |
| 18 |  $PAAS | PAN AMERICAN SILVER CORP | $4.5M | 2.5% | +0% | — |
| 19 |  $PSLV | Sprott Physical Silver Trust | $4.2M | 2.3% | +0% | — |
| 20 |  $TFPM | Triple Flag Precious Metals Corp. | $3.4M | 1.9% | +0% | — |
| 21 |  $ABEO | ABEONA THERAPEUTICS INC. | $3.0M | 1.7% | +0% | 23.7 |
| 22 |  $GROY | Gold Royalty Corp. | $2.8M | 1.5% | +0% | — |
| 23 |  $NEWP | NEW PACIFIC METALS CORP | $1.9M | 1.1% | +0% | — |
| 24 | — | iSHares US Aerospace & Defense - US AER DEF ETF | $1.9M | 1.0% | +0% | — |
| 25 |  $PM | Philip Morris International Inc. | $1.8M | 1.0% | +0% | 75.9 |
| 26 |  $CDE | Coeur Mining, Inc. | $1.6M | 0.9% | +0% | 82 |
| 27 |  $AGI | ALAMOS GOLD INC | $1.5M | 0.8% | +0% | — |
| 28 |  $WPM | Wheaton Precious Metals Corp. | $1.4M | 0.8% | +0% | — |
| 29 |  $NOC | NORTHROP GRUMMAN CORP /DE/ | $1.1M | 0.6% | +0% | 62.9 |
| 30 |  $ELE | Elemental Royalty Corp | $873,000 | 0.5% | +0% | — |
| 31 |  $VMET | Versamet Royalties Corp | $820,668 | 0.5% | +0% | — |
| 32 |  $DC | Dakota Gold Corp. | $523,643 | 0.3% | +0% | — |
| 33 |  $AMRZ | Amrize Ltd | $489,027 | 0.3% | +0% | — |
| 34 |  $ALT | Altimmune, Inc. | $486,400 | 0.3% | +0% | 8 |
| 35 |  $PHAR | Pharming Group N.V. | $56,823 | 0.0% | +1% | — |
| 36 | — | Orgenesis, Inc. - COM | $20,823 | 0.0% | +0% | — |
| 37 |  $BHVN | Biohaven Ltd. | $15 | 0.0% | +0% | — |
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Knoll Capital Management, LLC including:
Track Knoll Capital Management, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Knoll Capital Management, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Knoll Capital Management, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Knoll Capital Management, LLC (SEC CIK: 1325083), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Knoll Capital Management, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.